According to the 2013 St Gallen Consensus Conference, based on ER, PR, HER2, and Ki67 status, breast cancer patients are divided into different subtypes, including Luminal A, Luminal B, HER2-amplified, and triple-negative [7]. Here, ERBB2 is linked to breast carcinoma.